The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis

Authors: Muraishi, Nozomu, Kawamura, Yusuke, Akuta, Norio, Shindoh, Junichi, Matsumura, Masaru, Okubo, Satoshi, Fujiyama, Shunichiro, Hosaka, Tetsuya, Saitoh, Satoshi, Sezaki, Hitomi, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Ikeda, Kenji, Arase, Yasuji, Hashimoto, Masaji, Yasuda, Ichiro, Kumada, Hiromitsu

Source: Oncology. 101(2):134-144

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173262968.0x000001&indx=1&recIds=ETOCvdc_100173262968.0x000001

Favorable impact of long‐term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5‐year follow‐up study

Authors: Akuta, Norio, Kawamura, Yusuke, Fujiyama, Shunichiro, Saito, Satoshi, Muraishi, Nozomu, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Masahiro, Kobayashi, Mariko, Arase, Yasuji, Ikeda, Kenji, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Kumada, Hiromitsu

Source: Hepatology communications. 6(9):2286-2297

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190649477.0x000001&indx=1&recIds=ETOCvdc_100190649477.0x000001

Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage

Authors: Akuta, Norio, Kawamura, Yusuke, Suzuki, Fumitaka, Saitoh, Satoshi, Arase, Yasuji, Muraishi, Nozomu, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Masahiro, Kobayashi, Mariko, Suzuki, Yoshiyuki, Ikeda, Kenji, Kumada, Hiromitsu

Source: Oncology. 100(1):31-38

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138586306.0x000001&indx=1&recIds=ETOCvdc_100138586306.0x000001

Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma

Authors: Kawamura, Yusuke, Kobayashi, Masahiro, Shindoh, Junichi, Matsumura, Masaru, Okubo, Satoshi, Muraishi, Nozomu, Fujiyama, Shunichiro, Hosaka, Tetsuya, Saitoh, Satoshi, Sezaki, Hitomi, Akuta, Norio, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Ikeda, Kenji, Arase, Yasuji, Hashimoto, Masaji, Kumada, Hiromitsu

Source: Oncology. 100(6):320-330

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100151471848.0x000001&indx=1&recIds=ETOCvdc_100151471848.0x000001

Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection.

Authors: Tajiri, Kazuto, Hayashi, Yuka, Murayama, Aiko, Muraishi, Nozomu, Minemura, Masami, Yasuda, Ichiro

Source: Viruses (1999-4915); Jan2025, Vol. 17 Issue 1, p44, 11p

Subject Terms: HEPATITIS B, CHRONIC hepatitis B, HEPATIC fibrosis, HEPATITIS B virus, TENOFOVIR

Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease

Authors: Ochiai, Yorinari, Kawamura, Yusuke, Kobayashi, Masahiro, Shindoh, Junichi, Kobayashi, Yuta, Okubo, Satoshi, Muraishi, Nozomu, Kajiwara, Akira, Iritani, Soichi, Fujiyama, Shunichiro, Hosaka, Tetsuya, Saitoh, Satoshi, Sezaki, Hitomi, Akuta, Norio, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Ikeda, Kenji, Arase, Yasuji, Hashimoto, Masaji, Kumada, Hiromitsu

Source: Hepatology research. 51(1):62-68

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114740517.0x000001&indx=1&recIds=ETOCvdc_100114740517.0x000001

Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment

Authors: Yamashige, Daiki, Kawamura, Yusuke, Kobayashi, Masahiro, Shindoh, Junichi, Kobayashi, Yuta, Okubo, Satoshi, Muraishi, Nozomu, Kajiwara, Akira, Iritani, Soichi, Fujiyama, Shunichiro, Hosaka, Tetsuya, Saitoh, Satoshi, Sezaki, Hitomi, Akuta, Norio, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Ikeda, Kenji, Arase, Yasuji, Hashimoto, Masaji, Kumada, Hiromitsu

Source: Oncology. 99(3):169-176

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100116023059.0x000001&indx=1&recIds=ETOCvdc_100116023059.0x000001

Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment

Authors: Kawamura, Yusuke, Kobayashi, Masahiro, Shindoh, Junichi, Kobayashi, Yuta, Okubo, Satoshi, Muraishi, Nozomu, Iritani, Soichi, Fujiyama, Shunichiro, Hosaka, Tetsuya, Saitoh, Satoshi, Sezaki, Hitomi, Akuta, Norio, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Ikeda, Kenji, Arase, Yasuji, Hashimoto, Masaji, Kumada, Hiromitsu

Source: Oncology. 99(10):611-621

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100130255207.0x000001&indx=1&recIds=ETOCvdc_100130255207.0x000001

Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection.

Authors: Hayashi, Yuka, Tajiri, Kazuto, Ozawa, Tatsuhiko, Angata, Kiyohiko, Sato, Takashi, Togayachi, Akira, Nagashima, Izuru, Shimizu, Hiroki, Murayama, Aiko, Muraishi, Nozomu, Narimatsu, Hisashi, Yasuda, Ichiro

Source: Medicina (1010660X); Aug2024, Vol. 60 Issue 8, p1334, 16p

Subject Terms: HEPATITIS B, HEPATITIS associated antigen, CHRONIC hepatitis B, MONOCLONAL antibodies, EPITOPES

Impact of post‐progression survival in second‐line treatment with molecular target agents for unresectable hepatocellular carcinoma.

Authors: Tajiri, Kazuto¹ (AUTHOR) tajikazu@med.u-toyama.ac.jp, Muraishi, Nozomu¹ (AUTHOR), Murayama, Aiko¹ (AUTHOR), Hayashi, Yuka¹ (AUTHOR), Yasuda, Ichiro¹ (AUTHOR)

Source: Hepatology Research. Apr2024, Vol. 54 Issue 4, p403-408. 6p.

Subject Terms: *DRUG target, *PROGRESSION-free survival, *OVERALL survival, *DATABASES, *DISEASE progression, *HEPATOCELLULAR carcinoma

Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

Authors: Tajiri, Kazuto, Tsukada, Kenichiro, Tokimitsu, Yoshiharu, Motofuji, Yuchi, Kawai, Kengo, Muraishi, Nozomu, Murayama, Aiko, Hayashi, Yuka, Shimizu, Yukihiro, Yasuda, Ichiro

Source: Oncology; 2024, Vol. 102 Issue 2, p131-140, 10p

Subject Terms: THERAPEUTIC use of monoclonal antibodies, THERAPEUTIC use of antineoplastic agents, DISEASE progression, RETROSPECTIVE studies, ACQUISITION of data, TREATMENT effectiveness, CANCER patients, SURVIVAL analysis (Biometry), DESCRIPTIVE statistics, MEDICAL records, BEVACIZUMAB, PROGRESSION-free survival, HEPATOCELLULAR carcinoma, OVERALL survival

A Case of Immune-Related Aseptic Meningitis during Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma.

Authors: Kawanaka, Hiroki, Tajiri, Kazuto, Muraishi, Nozomu, Murayama, Aiko, Nukui, Takamasa, Yasuda, Ichiro

Source: Case Reports in Gastroenterology; 2024, Vol. 18 Issue 1, p8-13, 6p

Subject Terms: CONTRAST-enhanced magnetic resonance imaging, DRUG side effects, CEREBROSPINAL fluid examination, CEREBRAL sulci, ATEZOLIZUMAB, HEPATOCELLULAR carcinoma

A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan.

Authors: Yamaguchi, Satoshi, Yamazaki, Miho, Kido, Toshiki, Hounoki, Hiroyuki, Muraishi, Nozomu, Tajiri, Kazuto, Tanaka, Shinichi, Tobe, Kazuyuki, Shinoda, Koichiro

Source: Rheumatology; Apr2024, Vol. 63 Issue 4, pe120-e122, 3p

Subject Terms: VASCULITIS, HYPERCHOLESTEREMIA, MICROSCOPIC polyangiitis, ANTINEUTROPHIL cytoplasmic antibodies, BILE duct diseases, COMPLEMENT (Immunology), HEMATURIA, PREDNISOLONE, ANTI-infective agents, CO-trimoxazole, PNEUMOCYSTIS pneumonia, PYELONEPHRITIS, COUGH, METHYLPREDNISOLONE, OSTEOPOROSIS, C-reactive protein, CHOLESTASIS

An Autopsy Case of Ruptured Hepatic Angiosarcoma Treated by Transcatheter Arterial Embolization

Authors: Entani, Toshiki, Tajiri, Kazuto, Noguchi, Akira, Murayama, Aiko, Muraishi, Nozomu, Hayashi, Yuka, Yasuda, Ichiro

Source: Case Reports in Gastroenterology; October 2023, Vol. 17 Issue: 1 p309-315, 7p

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals.

Authors: Tajiri, Kazuto, Okada, Kazuhiko, Ito, Hiroyuki, Kawai, Kengo, Kashii, Yoshiro, Tokimitsu, Yoshiharu, Muraishi, Nozomu, Murayama, Aiko, Hayashi, Yuka, Minemura, Masami, Takahara, Terumi, Shimizu, Yukihiro, Yasuda, Ichiro

Source: BMC Gastroenterology; 5/25/2023, Vol. 23 Issue 1, p1-8, 8p

Subject Terms: ANTIVIRAL agents, HEPATIC fibrosis, HEPATITIS C virus, THROMBOCYTOPENIA, LEUCOPENIA

A ruptured sarcomatoid hepatocellular carcinoma treated with combined immunotherapy.

Authors: Goto, Yuno, Tajiri, Kazuto, Tanaka, Shinichi, Murayama, Aiko, Muraishi, Nozomu, Hayashi, Yuka, Yasuda, Ichiro

Source: Clinical Journal of Gastroenterology; Apr2023, Vol. 16 Issue 2, p244-249, 6p

A case of drug-induced acute liver failure caused by corticosteroids.

Authors: Kajiwara, Akira, Kawamura, Yusuke, Kinowaki, Keiichi, Muraishi, Nozomu, Iritani, Soichi, Akuta, Norio, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Saitoh, Satoshi, Kobayashi, Masahiro, Arase, Yasuji, Ikeda, Kenji, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Kumada, Hiromitsu

Source: Clinical Journal of Gastroenterology; Oct2022, Vol. 15 Issue 5, p946-952, 7p

Pretreatment Positron Emission Tomography with ¹⁸F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma.

Authors: Kawamura, Yusuke, Kobayashi, Masahiro, Shindoh, Junichi, Matsumura, Masaru, Okubo, Satoshi, Muraishi, Nozomu, Fujiyama, Shunichiro, Hosaka, Tetsuya, Saitoh, Satoshi, Sezaki, Hitomi, Akuta, Norio, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Ikeda, Kenji, Arase, Yasuji, Hashimoto, Masaji, Kumada, Hiromitsu

Source: Oncology; 2022, Vol. 100 Issue 6, p320-330, 11p

Subject Terms: THERAPEUTIC use of monoclonal antibodies, THERAPEUTIC use of antineoplastic agents, PREOPERATIVE care, DISEASE progression, CONFIDENCE intervals, MULTIVARIATE analysis, TREATMENT effectiveness, PROTEIN-tyrosine kinase inhibitors, RADIOPHARMACEUTICALS, POSITRON emission tomography, SURVIVAL analysis (Biometry), DEOXY sugars, BEVACIZUMAB, PROGRESSION-free survival, HEPATOCELLULAR carcinoma

The useful predictors of zinc deficiency for the management of chronic liver disease.

Authors: Iritani, Soichi, Kawamura, Yusuke, Muraishi, Nozomu, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Akuta, Norio, Kobayashi, Masahiro, Saitoh, Satoshi, Suzuki, Fumitaka, Arase, Yasuji, Ikeda, Kenji, Suzuki, Yoshiyuki, Kumada, Hiromitsu

Source: Journal of Gastroenterology; Apr2022, Vol. 57 Issue 4, p322-332, 11p

Subject Terms: LIVER diseases, ZINC, CHRONIC diseases, HEPATITIS C virus, HEPATITIS B virus

Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease.

Authors: Akuta, Norio, Kawamura, Yusuke, Suzuki, Fumitaka, Kobayashi, Mariko, Arase, Yasuji, Saitoh, Satoshi, Muraishi, Nozomu, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Masahiro, Suzuki, Yoshiyuki, Ikeda, Kenji, Kumada, Hiromitsu

Source: Hepatology International; Apr2022, Vol. 16 Issue 2, p412-422, 11p